文献速递消化与肝胆胰病理

非典型梭形细胞/多形性脂肪瘤样肿瘤55例:TP53改变是非典型多形性脂肪瘤样肿瘤的遗传标志

Atypical spindle cell/pleomorphic lipomatous tumour: a clinicopathologic, immunohistochemical and molecular study of 55 cases, highlighting TP53 gene alterations as a genetic hallmark of atypical pleomorphic lipomatous tumour.
PubMed 文献 · Histopathology · 2025-05-23

研究对55例非典型梭形细胞/多形性脂肪瘤样肿瘤(ASPLT)进行DNA二代测序和免疫组化,重点分析TP53基因。21例非典型多形性脂肪瘤样肿瘤(APLT)中20例(95%)存在TP53改变,而非典型梭形细胞脂肪瘤样肿瘤(ASLT)未见TP53改变;p53免疫组化异常且测序成功的APLT中92%(12/13)携带TP53改变。结论支持APLT为独立亚实体,p53免疫组化有助于鉴别ASLT与APLT。

要点

  • APLT中TP53改变检出率高达95%(20/21),而ASLT未见TP53改变。
  • p53免疫组化异常且测序成功的APLT中92%(12/13)存在TP53改变。
  • p53免疫组化可作为鉴别ASLT与APLT的辅助诊断工具。

核心结论

  • APLT主要携带TP53改变,而ASLT未见TP53改变,支持APLT作为与ASLT重叠谱系中的独立亚实体。
  • p53免疫组化是区分ASLT与APLT的潜在有价值诊断工具。

研究设计与样本

  • 基于DNA的二代测序和免疫组化研究,共55例ASPLT病例,重点分析TP53基因。

主要发现

  • 21例APLT中20例(95%)检出TP53改变。
  • ASLT病例中未观察到TP53改变。
  • p53免疫组化异常且DNA测序成功的APLT中,92%(12/13)携带TP53改变。

关键数值与推荐

  • APLT中TP53改变检出率为95%(20/21)。
  • p53免疫组化异常且测序成功的APLT中TP53改变比例为92%(12/13)。

临床怎么用

  • 病理诊断中可借助p53免疫组化辅助鉴别ASLT与APLT。
  • APLT应被视为与ASLT重叠谱系中的独立亚实体进行报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Atypical spindle cell lipomatous tumour (ASLT) and atypical pleomorphic lipomatous tumour (APLT) have been grouped together under the umbrella designation atypical spindle cell/pleomorphic lipomatous tumour (ASPLT) in the 2020 edition of the World Health Organization (WHO) Classification of Soft Tissue and Bone Tumours. They are thought to exist on a morphologic spectrum and share similar clinicopathologic and biological characteristics. The aim of this study was to further explore the genetic background of ASLTs and APLTs by employing DNA-based next-generation sequencing and immunohistochemistry, with a specific focus on the TP53 gene. METHODS AND RESULTS: Using DNA-based NGS and immunohistochemistry, TP53 alterations were identified in 20 out of 21 APLT cases (95%). This is in contrast to the ASLT cases, in which no TP53 alterations could be observed. Among APLT cases with an abnormal p53 immunohistochemical profile and successful DNA NGS testing, 92% (12 of 13 cases) harboured a TP53 alteration. CONCLUSIONS: APLTs predominantly harbour a TP53 alteration in contrast to ASLT cases. Our findings support the classification of APLT as a distinct (sub)entity within a spectrum that overlaps with ASLT, and it remains to be determined whether the broader term 'ASPLT' will hold up. Furthermore, p53 immunostaining proved to be a potentially valuable diagnostic tool, aiding pathologists in differentiating between ASLT and APLT.

来源:Histopathology,查看原文。版权归原作者所有。

引用

  1. Cordier F, Kleijn TG, Mentzel T, et al. Atypical spindle cell/pleomorphic lipomatous tumour: a clinicopathologic, immunohistochemical and molecular study of 55 cases, highlighting TP53 gene alterations as a genetic hallmark of atypical pleomorphic lipomatous tumour. Histopathology. 2025. PMID: 40405626. doi:10.1111/his.15474

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。